• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

Diabeloop raises $74.9M Series C

June 2, 2022 By Sean Whooley

Diabeloop logo - largeDiabeloop announced today that it raised approximately $74.9 million (€70 million) in a Series C financing round.

LBO France, a private equity player, led the financing round, while Terumo — with which Diabeloop has partnered since 2020 — also participated in the round.

Innovacom joined LBO France and Terumo as new investors, according to a news release. Previous investors CERITD, CEMAG Invest, Kreaxi, Supernova Invest, AGIR A DOM., Crédit Agricole, Odyssée Venture, UI Inventissement (Sofimac) and Promontoires all elected to reinvest, Diabeloop said, while Bpifrance and the historical bank pool support the company via debt financing.

Paris-based Diabeloop develops machine learning software for diabetes treatment. Its algorithms are integrated into easy-to-use products to facilitate chronic disease management.

The company has commercialized closed-loop solutions for personalized management for type 1 diabetes and highly unstable type 1 diabetes, connecting a continuous glucose monitor (CGM) and insulin pump for insulin therapy with the algorithms analyzing data in real-time and providing automated insulin delivery.

“Being able in 2021 to bring the benefits of our products to thousands of patients and hearing their enthusiasm, is why all of us at Diabeloop work so hard,” Diabeloop founder and CEO Erik Huneker said in the release. “The financing round announced today recognizes the team’s successes, and more importantly, the great opportunities ahead.”

Filed Under: Auto-injectors, Big Data, Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Funding Roundup, Pain Management, Technology Tagged With: Diabeloop

IN CASE YOU MISSED IT

  • Retractable Technologies declares dividends
  • Teva appoints former Vertex exec as new head of R&D, CMO
  • West Pharmaceutical Services debuts new needle syringe system
  • CeQur is launching a discreet, convenient ‘wearable insulin pen’
  • Dexcom focuses on early diabetes diagnosis as COVID links emerge

Primary Sidebar

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Drug Delivery Business News in a minute? We Deliver!
Drug Delivery Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

Signup for the newsletter

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing & Extrusion
Medical Design & Outsourcing
MedTech 100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Souring
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts
Add us on FacebookFollow us on TwitterConnect with us on LinkedIn

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS